{"log_id": 603443608206295456, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 2e-06, "average": 0.998063, "min": 0.997011}, "location": {"width": 49, "top": 145, "height": 26, "left": 121}, "words": "险)。"}, {"probability": {"variance": 9e-06, "average": 0.99857, "min": 0.984972}, "location": {"width": 559, "top": 191, "height": 40, "left": 204}, "words": "在严重肾功能不全的患者中联合应用吉西他滨与顺铂"}, {"probability": {"variance": 1e-06, "average": 0.999448, "min": 0.997125}, "location": {"width": 131, "top": 239, "height": 30, "left": 129}, "words": "【注意事项】"}, {"probability": {"variance": 2.2e-05, "average": 0.99785, "min": 0.978923}, "location": {"width": 488, "top": 289, "height": 37, "left": 168}, "words": "延长输液时间和增加给药频率都可能增加毒性"}, {"probability": {"variance": 0, "average": 0.999894, "min": 0.999716}, "location": {"width": 123, "top": 338, "height": 31, "left": 119}, "words": "血液学毒性"}, {"probability": {"variance": 0, "average": 0.99962, "min": 0.998275}, "location": {"width": 853, "top": 386, "height": 44, "left": 165}, "words": "吉西他滨可能引起骨髓功能抑制,应用后可出现白细胞减少、血小板减少和贫血"}, {"probability": {"variance": 2e-06, "average": 0.999213, "min": 0.993575}, "location": {"width": 949, "top": 434, "height": 45, "left": 164}, "words": "患者在每次接受吉西他滨治疗前,必须监测血小板、白细胞、粒细胞计数。当证实有药物"}, {"probability": {"variance": 9.9e-05, "average": 0.996934, "min": 0.938545}, "location": {"width": 993, "top": 480, "height": 46, "left": 116}, "words": "引起的骨髓抑制时,应暂停化疗或修改治疗方案(见【用法用量】)。然而,骨髓抑制持续时间"}, {"probability": {"variance": 2e-06, "average": 0.999517, "min": 0.993296}, "location": {"width": 535, "top": 528, "height": 37, "left": 115}, "words": "短,通常不需降低剂量,很少有停止治疗情况发生"}, {"probability": {"variance": 2e-06, "average": 0.999307, "min": 0.992914}, "location": {"width": 924, "top": 576, "height": 45, "left": 162}, "words": "停用吉西他滨后,外周血细胞计数可能继续下降。骨髓功能受损的患者,用药应当谨慎"}, {"probability": {"variance": 1.3e-05, "average": 0.998553, "min": 0.980304}, "location": {"width": 847, "top": 623, "height": 44, "left": 116}, "words": "与其它的抗肿瘤药物配伍进行联合或序贯化疗时,应考虑对骨髓抑制作用的蓄积"}, {"probability": {"variance": 1e-06, "average": 0.99923, "min": 0.99715}, "location": {"width": 124, "top": 672, "height": 31, "left": 112}, "words": "肝功能不全"}, {"probability": {"variance": 7e-05, "average": 0.997289, "min": 0.947256}, "location": {"width": 948, "top": 719, "height": 46, "left": 158}, "words": "给已经出现肝转移的患者或既往有肝炎、酗酒或肝硬化病史的患者使用吉西他滨,可能会"}, {"probability": {"variance": 0, "average": 0.9994, "min": 0.998188}, "location": {"width": 267, "top": 768, "height": 30, "left": 113}, "words": "导致潜在肝功能不全恶化"}, {"probability": {"variance": 1e-06, "average": 0.999235, "min": 0.994399}, "location": {"width": 680, "top": 815, "height": 39, "left": 158}, "words": "应定期对患者进行肾和肝功能(包括病毒学检查)的实验室评价"}, {"probability": {"variance": 1.5e-05, "average": 0.998537, "min": 0.979854}, "location": {"width": 948, "top": 861, "height": 46, "left": 158}, "words": "由于没有从临床研究中获得关于这些患者群明确剂量推荐的充分信息,因此,对于有肝功"}, {"probability": {"variance": 1e-06, "average": 0.999411, "min": 0.994047}, "location": {"width": 996, "top": 909, "height": 45, "left": 108}, "words": "能不全或肾功能损伤的患者,应该慎用吉西他滨,因为关于这类患者的临床研究资料还不够充"}, {"probability": {"variance": 8.3e-05, "average": 0.996316, "min": 0.95505}, "location": {"width": 591, "top": 957, "height": 38, "left": 110}, "words": "分,尚不能据此得出明确的推荐剂量。(见【用法用量】)"}, {"probability": {"variance": 1.4e-05, "average": 0.997962, "min": 0.990607}, "location": {"width": 122, "top": 1008, "height": 29, "left": 108}, "words": "同步放化疗"}, {"probability": {"variance": 0.001514, "average": 0.99082, "min": 0.754671}, "location": {"width": 941, "top": 1052, "height": 45, "left": 156}, "words": "同步放化疗(放化疗一起应用或者不同治疗间的间隔二7天):已报告有毒性反应发生(详"}, {"probability": {"variance": 3.1e-05, "average": 0.997175, "min": 0.97782}, "location": {"width": 410, "top": 1100, "height": 35, "left": 108}, "words": "细信息和推荐剂量见【药物相互作用】"}, {"probability": {"variance": 0.000118, "average": 0.992958, "min": 0.955785}, "location": {"width": 708, "top": 1146, "height": 44, "left": 153}, "words": "放疗的同时给予1000mg/m2的吉西他滨可导致严重的肺或食管病变"}, {"probability": {"variance": 0.000107, "average": 0.996605, "min": 0.950358}, "location": {"width": 945, "top": 1194, "height": 46, "left": 154}, "words": "如果吉西他滨与放射治疗连续给予,由于严重辐射敏化的可能性,吉西他滨化疗与放射治"}, {"probability": {"variance": 0.006691, "average": 0.977688, "min": 0.624352}, "location": {"width": 772, "top": 1241, "height": 54, "left": 104}, "words": "疗的间隔至少4周。如果患者情况允许可缩短间隔时间。豪森药业集团"}, {"probability": {"variance": 0, "average": 0.999792, "min": 0.9996}, "location": {"width": 74, "top": 1294, "height": 28, "left": 105}, "words": "活疫苗"}, {"probability": {"variance": 4e-06, "average": 0.998744, "min": 0.99522}, "location": {"width": 170, "top": 1284, "height": 56, "left": 726}, "words": "有限公司"}, {"probability": {"variance": 0.000155, "average": 0.995535, "min": 0.938438}, "location": {"width": 930, "top": 1337, "height": 45, "left": 152}, "words": "不推荐接受吉西他滨治疗的患者使用黄热病疫苗和其它减毒活疫苗(见【药物相互作用】)"}, {"probability": {"variance": 1e-06, "average": 0.999288, "min": 0.996981}, "location": {"width": 123, "top": 1387, "height": 30, "left": 101}, "words": "心血管系统"}, {"probability": {"variance": 1e-06, "average": 0.9994, "min": 0.995599}, "location": {"width": 947, "top": 1432, "height": 45, "left": 151}, "words": "由于吉西他滨可引起心脏和或心血管病症,因此具有心血管疾患病史的患者使用吉西他滨"}, {"probability": {"variance": 3e-06, "average": 0.997697, "min": 0.995229}, "location": {"width": 149, "top": 1481, "height": 28, "left": 99}, "words": "时要特别谨慎"}, {"probability": {"variance": 0, "average": 0.999833, "min": 0.999833}, "location": {"width": 29, "top": 1530, "height": 27, "left": 99}, "words": "肺"}, {"probability": {"variance": 1e-06, "average": 0.999258, "min": 0.995778}, "location": {"width": 943, "top": 1573, "height": 46, "left": 151}, "words": "与吉西他滨治疗相关的肺部症状,有时甚至是严重肺部症状(如肺水肿、间质性肺炎或成"}], "language": 3}